An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells. Issue 3 (April 2016)
- Record Type:
- Journal Article
- Title:
- An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells. Issue 3 (April 2016)
- Main Title:
- An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells
- Authors:
- Kondo, Kenta
Fujiki, Fumihiro
Nakajima, Hiroko
Yatsukawa, Erika
Morimoto, Soyoko
Tatsumi, Naoya
Nishida, Sumiyuki
Nakata, Jun
Oka, Yoshihiro
Tsuboi, Akihiro
Hosen, Naoki
Oji, Yusuke
Sugiyama, Haruo - Abstract:
- Abstract : Many studies demonstrated crucial roles of avidity of T-cell receptor (TCR) in T-cell fate. However, majority of these findings resulted from analysis of non–self-antigen-specific CD8 + T cells, and little is known about roles of TCR avidity in the fate of self-antigen-specific CD8 + T cells. Wilms tumor gene 1 (WT1) protein is a self-antigen most suitable for addressing this issue because WT1 protein is a highly immunogenic, typical self-antigen. Here, we isolated 2 distinct and functional TCRs, TCR1 and TCR2, from murine WT1 peptide (RMFPNAPYL)-specific cytotoxic T lymphocytes (WT1-CTLs) and generated TCR1-retrogenic (Rg) and TCR2-Rg mice under T and B-cell-deficient and -reconstituted conditions. TCR1-transduced CD8 + T (TCR1-T) cells had approximately 2-fold higher avidity to WT1 peptide than TCR2-transduced CD8 + T (TCR2-T) cells. Cytokine production profiles and cell surface phenotypes showed that TCR1-T cells were more differentiated than TCR2-T cells under both conditions. Therefore, TCR1-T cells with TCR avidity higher than that of TCR2-T cells are more differentiated compared with TCR2-T cells. Furthermore, TCR1-T cells that developed under T and B-cell-reconstituted conditions displayed cytotoxicity against endogenously WT1-expressing tumor cells, whereas TCR2 T cells that developed under the same conditions did not. Thus, it was demonstrated, for the first time, that TCR avidity played an essential role in differentiation of self-antigen-reactive TAbstract : Many studies demonstrated crucial roles of avidity of T-cell receptor (TCR) in T-cell fate. However, majority of these findings resulted from analysis of non–self-antigen-specific CD8 + T cells, and little is known about roles of TCR avidity in the fate of self-antigen-specific CD8 + T cells. Wilms tumor gene 1 (WT1) protein is a self-antigen most suitable for addressing this issue because WT1 protein is a highly immunogenic, typical self-antigen. Here, we isolated 2 distinct and functional TCRs, TCR1 and TCR2, from murine WT1 peptide (RMFPNAPYL)-specific cytotoxic T lymphocytes (WT1-CTLs) and generated TCR1-retrogenic (Rg) and TCR2-Rg mice under T and B-cell-deficient and -reconstituted conditions. TCR1-transduced CD8 + T (TCR1-T) cells had approximately 2-fold higher avidity to WT1 peptide than TCR2-transduced CD8 + T (TCR2-T) cells. Cytokine production profiles and cell surface phenotypes showed that TCR1-T cells were more differentiated than TCR2-T cells under both conditions. Therefore, TCR1-T cells with TCR avidity higher than that of TCR2-T cells are more differentiated compared with TCR2-T cells. Furthermore, TCR1-T cells that developed under T and B-cell-reconstituted conditions displayed cytotoxicity against endogenously WT1-expressing tumor cells, whereas TCR2 T cells that developed under the same conditions did not. Thus, it was demonstrated, for the first time, that TCR avidity played an essential role in differentiation of self-antigen-reactive T cells, through the success of establishment of two distinct WT1-CTLs with a difference in only TCR avidity under the identical genetic background. Present results should provide us with an insight for elucidation of the differentiation mechanisms of self-antigen-reactive T cells, including tumor antigen–reactive T cells. … (more)
- Is Part Of:
- Journal of immunotherapy. Volume 39:Issue 3(2016:Apr.)
- Journal:
- Journal of immunotherapy
- Issue:
- Volume 39:Issue 3(2016:Apr.)
- Issue Display:
- Volume 39, Issue 3 (2016)
- Year:
- 2016
- Volume:
- 39
- Issue:
- 3
- Issue Sort Value:
- 2016-0039-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-04
- Subjects:
- WT1 -- TCR avidity -- self-antigen -- T-cell fate
Immunotherapy -- Periodicals
Immunotherapy -- Periodicals
Neoplasms -- therapy -- Periodicals
Electronic journals
Electronic journals
615.37 - Journal URLs:
- http://www.immunotherapy-journal.com/ ↗
http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=00002371-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/CJI.0000000000000114 ↗
- Languages:
- English
- ISSNs:
- 1524-9557
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5005.040000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5187.xml